Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“Follow MedCity News if you want to know who is doing what in healthcare innovation - and whether it's working or not.”

Chris Seper, CEO & Founder, MedCityNews.com


Sign up for our daily newsletter


Device firm treating atrial fibrillation with catheter-based therapy seeks $14 million

November 14, 2012 12:08 pm by | 0 Comments

dollars, wealth

A Carlsbad, California device start-up is seeking $14 million to develop its atrial fibrillation treatment, according to a regulatory filing.

Medical Device Innovations Inc., which has developed a catheter-based therapy to treat AF, is expecting to close the $14 million round by the end of the year, said Chris Kunis, founder and CTO. He added that the lead investor will be Versant Ventures.

A previous,angel round of funding in October, 2011, brought in $1.1 million, Kunis said.

Advertisement

The $14 million funding would be used to run clinical trials, among other things, of “a game-changing technology” to treat AF. However, Kunis declined to provide details about it saying that it was “under wraps” precisely because it was so novel. He did reveal that the catheter-based technology is a “passive system” that doesn’t rely on any energy source and has been shown to, over the long term, isolate the pulmonary vein. That is in contrast to current catheter-based ablation techniques that use heat or cold energy to try and isolate the pulmonary veins that are known to generate atrial fibrillation.

On its website, MDI says that ablation has several limitations – the procedures are long, technically challenging and require highly skilled clinicians.

The CEO of the company is Michael Dale, who is the former CEO of ATS Medical, which was acquired by Medtronic in 2010.

 

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments